A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease
Clinical trial NCT05531656 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05531656
- Sponsor
- Cognition Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-28
- Primary completion
- 2027-05-31
- Enrollment
- 540
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.